Skip to main content
. 2020 Jan 16;2(1):7–10. doi: 10.1097/BS9.0000000000000034

Figure 2.

Figure 2

The scheme of PML/RARα-driven APL pathogenesis. The oncoprotein PML/RARα drives disruption of PML nuclear bodies while P/R-multimer exerts target genes in deregulation and recruits DBF (RXR, PU.1 and many others) to form hetero-multimers, which in turn might enhance CoR recruitment, leading to abnormal cell arrest.